Semaglutide may be a good starting option for individuals beginning GLP-1 treatment, while tirzepatide may be considered when additional appetite control or metabolic support is needed
GLP-1 ((glucagon-like peptide-1) drugs such as semaglutide work by mimicking a natural hormone that signals the brain to feel full and slows down digestion, helping one eat less and lose weight more effectively
Mainly expressed in the ileum and colon, GLP-1 is known as the most powerful incretin in humans and lowers postprandial blood glucose via augmentation of glucose-dependent insulin release from pancreatic -cells, inhibition of glucagon secretion from pancreatic -cells, and delay of GE
Why Mood Effects Are Even Being Considered GLP-1 receptors are found in brain regions involved in: Appetite regulation Reward and motivation Stress response Emotional processing Because these medications cross into the central nervous system, researchers have long studied whether they might affect mood, anxiety, or emotional regulation
In the initial phase I clinical trial for MT-II conducted to evaluate the peptides safety and tanning potential, all subjects administered MT-II experienced statistically significant skin darkening [5]